Highlights:
Janney Montgomery Scott LLC reduced its stake in CVS Health by 24.8% during Q3 2024.
CVS Health’s quarterly revenue increased by 2.6% year-over-year, with a return on equity of 12.72%.
The company announced a quarterly dividend with a yield of 4.81%, marking a 47.33% payout ratio.
Janney Montgomery Scott LLC decreased its position in CVS Health (NYSE:CVS) by 24.8% in the third quarter of 2024, as disclosed in a recent filing with the Securities and Exchange Commission (SEC). After selling 111,292 shares during the quarter, the institutional firm held 338,239 shares of the pharmacy operator. Despite this reduction, CVS Health remains a significant player in the health services sector, with institutional investors and hedge funds collectively holding 80.66% of the company’s stock.
CVS Health, a key provider of health solutions in the United States, reported a steady performance in its latest quarterly earnings. For the quarter ending in August 2024, the company achieved earnings per share of $1.83, surpassing analysts’ consensus estimates. Revenue for the period reached $91.23 billion, a slight increase of 2.6% compared to the same quarter in the previous year. The company’s return on equity stood at 12.72%, reflecting its ability to generate profits from shareholder equity, while its net margin was 1.98%.
In addition to its robust financial results, CVS Health continues to prioritize shareholder returns. The company declared a quarterly dividend of $0.665 per share, translating to an annualized dividend of $2.66, which represents a yield of 4.81%. The dividend payout ratio is 47.33%, indicating a balanced approach to distributing earnings while retaining sufficient funds for reinvestment.
Despite fluctuations in market sentiment, CVS Health remains a significant player in the healthcare and pharmacy sectors, with strong institutional backing and a focus on sustainable growth. With a market capitalization of $69.60 billion, the company continues to attract attention from analysts, many of whom maintain a positive outlook on its performance.